These findings also suggest that extrinsic modification of Stat3 activity affects Tgfb3 signaling, and might be a potential therapeutic target in pharmaceutical intervention for cleft palate (Sarper et al., 2018). This evidence concerns the gene STAT3 and cleft palate.